Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 460, Issue 4, Pages 931-937Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2015.03.129
Keywords
NCX; Ca2+ overload; Hypoxia; miR-132; Cardiomyocyte; Apoptosis
Categories
Funding
- Korea Science and Engineering Foundation - Korean government (MEST) [2014030459]
- Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A120478]
Ask authors/readers for more resources
During ischemia-reperfusion (IR) injury of the heart, Ca2+ overload occurs, leading to cardiomyocyte dysfunction and eventual cell death by apoptosis. Since preventing Ca2+ overload during IR injury has been reported to protect cardiomyocytes, interrupting Ca2+ signaling cascades leading to Ca2+ overload may exert protective effect on cardiomyocytes under hypoxic condition. One of the key regulators of the intracellular Ca2+ level during IR injury is Na+-Ca2+ exchanger 1 (NOX1), whose down-regulation during IR injury conferred protection of heart. In the present study, we examined whether down-regulation of NCX1 using exogenous microRNA ameliorates apoptosis of cardiomyocytes under hypoxic condition. Here, we identified miR-132 as a novel microRNA targeting the NCX1, whose expression increased during hypoxia. Delivery of miR-132 suppressed the increase of intracellular Ca2+ in cardiomyocytes under hypoxia, and the expressions of apoptotic molecules, such as Bax, cytochrome C, and caspase 3, and the number of apoptotic cells were also decreased by exogenous miR-132 treatment. These results suggest the potential of miR-132 as an effective therapeutic agent against IR damage to heart by preventing Ca2+ overload during hypoxic condition and warrant further studies to validate its anti-apoptotic effect in vivo. (C) 2015 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available